|
|
Volumn 12, Issue 3, 2002, Pages 286-289
|
|
Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer
a
|
|
Author keywords
Endometrial cancer; Immunohistochemical; Recurrence
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
ESTROGEN RECEPTOR;
KI 67 ANTIGEN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 124;
MONOCLONAL ANTIBODY 1801;
MONOCLONAL ANTIBODY 6F11;
MONOCLONAL ANTIBODY 9E10;
MONOCLONAL ANTIBODY CB11;
MONOCLONAL ANTIBODY F8 86;
MONOCLONAL ANTIBODY KI 67;
MONOCLONAL ANTIBODY PAB 1801;
MYC PROTEIN;
NEU DIFFERENTIATION FACTOR;
PROGESTERONE RECEPTOR;
PROTEIN BCL 2;
PROTEIN P53;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CANCER INVASION;
CANCER RECURRENCE;
CANCER STAGING;
CONTROLLED STUDY;
ENDOMETRIUM CANCER;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
METASTASIS;
MULTIPLE REGRESSION;
PELVIS LYMPHADENECTOMY;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
TUMOR DIFFERENTIATION;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
DNA, NEOPLASM;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM PROTEINS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PROGNOSIS;
PROSPECTIVE STUDIES;
RISK FACTORS;
TUMOR MARKERS, BIOLOGICAL;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0036071264
PISSN: 1048891X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1438.2002.t01-1-01103.x Document Type: Article |
|
Times cited : (22)
|
|
References (13)
|
